CAS RN: 422270-29-9
(R)-1-(4-fluorobenzyl)-3-methylpiperazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250404
100mg / 250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g, 0.25g, 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 422270-29-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
422270-29-9 / 1-[(4-fluorophenyl)methyl]-3-methylpiperazine
Standard CAS: 422270-29-9
Multi CAS: Yes
Basic Information
copy
CAS
422270-29-9 copy
Multi CAS
Yes copy
Molecular Formula
C12FH17N2 copy
Molecular Weight
208.270000 copy
Exact Mass
208.137577 copy
InChI
InChI=1S/C12H17FN2/c1-10-8-15(7-6-14-10)9-11-2-4-12(13)5-3-11/h2-5,10,14H,6-9H2,1H3 copy
InChIKey
NPIPCQHHNIFPQW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
59.14 copy
TPSA
15.27 copy
LogP / Solubility
WLOGP
1.62 copy
MLOGP
1.43 copy
XLogP3
1.6 copy
Consensus LogP
1.55 copy
Log S (ESOL)
-2.32 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.44 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.6 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.84 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy